12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Deals

genOway, StemCells deal

genOway received exclusive, worldwide rights to StemCells' Internal Ribosome Entry Site (IRES) technology to develop and...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >